First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Sees Significant Growth in Short Interest

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 400 shares, an increase of 100.0% from the November 30th total of 200 shares. Based on an average daily trading volume, of 2,900 shares, the short-interest ratio is presently 0.1 days.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

Shares of First Trust Nasdaq Pharmaceuticals ETF stock traded down $0.15 during trading on Friday, reaching $27.24. The company had a trading volume of 1,314 shares, compared to its average volume of 4,948. First Trust Nasdaq Pharmaceuticals ETF has a fifty-two week low of $25.73 and a fifty-two week high of $29.72. The firm’s fifty day moving average is $27.95 and its 200-day moving average is $28.25. The company has a market cap of $16.34 million, a price-to-earnings ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently announced a dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Friday, December 13th will be given a $0.1304 dividend. This is a positive change from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13. The ex-dividend date is Friday, December 13th.

Institutional Investors Weigh In On First Trust Nasdaq Pharmaceuticals ETF

An institutional investor recently bought a new position in First Trust Nasdaq Pharmaceuticals ETF stock. International Assets Investment Management LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,662 shares of the company’s stock, valued at approximately $73,000. International Assets Investment Management LLC owned about 0.41% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent SEC filing.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.